PLAINSBORO, N.J., Aug. 9, 2011 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the global market introduction of the Zuma-CTM Anterior Cervical Fixation System, expanding Integra’s spine product portfolio with the addition of its first integrated plate and interbody cervical device. Its design is based on the original ZumaTM platform, which has several years of successful use in the anterior lumbar spine. Offering a wide variety of implant sizes, combined with a comprehensive set of color-coded instrumentation, it provides an easy-to-use solution for anterior cervical discectomy and fusion, a surgical procedure performed to remove a herniated or degenerative disc in the neck.
The Zuma-CTM system features the benefits of a low-profile anterior fixation plate and a radiolucent interbody in an integrated, user-friendly device. The short articulating plate allows for optimal screw placement in bone and provides a favorable biomechanical environment, “I particularly like the short plate and the ability to fuse an adjacent segment without having to remove prior instrumentation,” said Farzad Massoudi, MD, surgeon designer for the Zuma-CTM system.
Dr. Lokesh Tantuwaya, another surgeon who assisted in the design of the Zuma-CTM system, said, “The integrated plate and spacer gives me confidence because of its biomechanical strength and its ability to facilitate ideal plate alignment on the vertebral bodies, which greatly reduces my OR time.”*
“Executing on this innovative product launch during the integration of SeaSpine is a testament to the focus and dedication of our team,” said Brian Larkin, Global President, Spine and Orthobiologics, and Head of Strategic Development for Integra, “Integra has a long history of successfully integrating companies to drive growth. We plan to continue this tradition in spine.”
Integra sells the Zuma-CTM Anterior Cervical Fixation System worldwide, and is a leading provider of fusion implants and orthobiologics used in spinal surgery. Integra’s Cervical portfolio also includes the Manta RayTM Anterior Cervical Plate, TetherTM Anterior Cervical Plate, CordantTM Anterior Cervical Plate, SonomaTM Anterior Cervical Plate, AtollTM Posterior Cervical System, SierraTM Posterior Fusion System, Vu cPODTM (non-strut) Intervertebral Body Fusion Device, CambriaTM Intervertebral Body Device , and the CapistranoTM Allograft Spacer.
Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive, and general surgery. For more information, please visit www.integralife.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the products and services provided by Integra. Such forward looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the willingness of surgical professionals to use Integra products may affect the prospects for their use in surgical procedures. In addition, the economic, competitive, governmental, technological and other factors, identified under the heading “Risk Factors” included in Item IA of Integra’s Annual Report on Form 10-K for the year ended December 31, 2010 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
*Based upon patient pathology and medical history, individual results may vary.
